Skip to search formSkip to main contentSkip to account menu

mofebutazone

Known as: 1-phenyl-4-n-butyl-3,5-dioxopyrazolidine, monophenylbutazone 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
HPLC-determination of naproxen, indomethacin, ketoprofen, fenoprofen ibuprofen, diclofenac sodium, tolfenamic acid… 
2007
2007
The gastroduodenal mucosa in dogs experimentally treated with nimesulide, monophenylbutazone and meloxicam was evaluated. There… 
1995
1995
Twenty-seven human volunteer asthmatic patients were each given one tablet of mofebutazone (300 mg) twice daily for 15 days… 
1994
1994
The phagocytosis and the release of oxidative products generated by the respiratory burst have been studied under the influence… 
1991
1991
The solid-state 13C NMR spectra of mofebutazone, phenylbutazone, and oxyphenbutazone monohydrate and anhydrate are presented. The… 
1987
1987
The crystal structure of the keto form of phenylbutazone has been determined and compared with the molecular conformation of… 
1983
1983
Several pharmacologically active cyclic diketone carbon acids, including phenylbutazone and 2-phenyl-1,3-indandione, catalyze the… 
1972
1972
SummaryThe authors describe toxic epidermal necrolysis and report on the clinical observation and post mortem findings in a 5… 
1969
1969
A double-blind trial has been carried out to compare the effects of monobutazone and phenylbutazone in ambulant outpatients with…